ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that, in cooperation with the Emirates Cardiac Society (ECS), it will host the first Dubai Cardiac Arrest Symposium on February 22 at the Crowne Plaza Dubai (Sheikh Zayed Rd.).
The scientific program will address improving outcomes in resuscitation in the Gulf and Arab states. The opening speaker is the chairman of the event, Alawi Alsheikh-Ali, MD, President of ECS, who will present “Cardiac arrest in the Gulf Where are the data?”
In addition, leading experts in cardiology from around the world will address related topics such as CPR awareness; high-quality CPR in relationship to success; pre-hospital cardiac arrest management from pavement to PCI; and AutoPulse®-facilitated PCI for out-of-hospital cardiac arrest. A sudden cardiac arrest survivor will conclude the symposium with a presentation entitled “I shouldn’t be alive.”
“Sudden cardiac arrest is the leading cause of unexpected death around the world, killing as many as 1 million people annually,” said Jonathan A. Rennert, President of ZOLL,“yet many of these deaths are potentially preventable when high-quality CPR is delivered. Advancing resuscitation care could improve survival from this major worldwide health problem.”
The symposium is expected to attract an audience of cardiologists, emergency physicians, anesthesiologists, and resuscitation officers and directors from throughout the Middle East. To view the agenda and register, please visit zoll.com/dcas. CME accreditation is available.
About Emirates Cardiac Society
The Emirates Cardiac Society (ESC) is a network of all cardiologists in the United Arab Emirates (UAE) that works under the umbrella of Emirates Medical Association. Its mission is to educate public and healthcare professionals in reducing the burden of cardiovascular disease in the UAE. The ECS promotes health education within the community, raises awareness of health issues among the general population, and establishes strong partnerships with national and international health agencies and establishments.
About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com), an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.
About Asahi Kasei
The Asahi Kasei Group (asahi-kasei.co.jp) is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.
Copyright © 2014 ZOLL Medical Corporation. All rights reserved. AutoPulse and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All product names are the property of their respective owners.